Literature Highlights - August 2023
AURORA 2, Voclosporin, Lupus Nephritis, BLISS-LN, Belimumab
Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.
This activity is supported by an educational grant from AstraZeneca.
AURORA 2, Voclosporin, Lupus Nephritis, BLISS-LN, Belimumab
Dörner T, et al. Ann Rheum Dis. 2022. Epub ahead of print. doi:10.1136/annrheumdis-2022-222335.
Phase II study results suggest that baricitinib 4 mg downregulates key cytokines that are upregulated in patients with SLE.